Free Trial

149,299 Shares in Medical Properties Trust, Inc. $MPW Acquired by Aristeia Capital L.L.C.

Medical Properties Trust logo with Finance background

Key Points

  • Aristeia Capital L.L.C. has made a new investment of approximately $900,000 in Medical Properties Trust, acquiring 149,299 shares of the company during the first quarter.
  • Wall Street analysts have mixed ratings for Medical Properties Trust, with two analysts giving a Buy rating, while the majority maintain a Hold rating and two others have downgraded to Sell.
  • The company recently declared a quarterly dividend of $0.08 per share, representing an annual yield of 6.9%, with a dividend payout ratio of -13.39%.
  • Interested in Medical Properties Trust? Here are five stocks we like better.

Aristeia Capital L.L.C. purchased a new position in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 149,299 shares of the real estate investment trust's stock, valued at approximately $900,000.

A number of other large investors also recently bought and sold shares of MPW. Versant Capital Management Inc raised its holdings in Medical Properties Trust by 98.1% in the 1st quarter. Versant Capital Management Inc now owns 6,180 shares of the real estate investment trust's stock worth $37,000 after purchasing an additional 3,060 shares during the period. GF Fund Management CO. LTD. acquired a new position in Medical Properties Trust in the 4th quarter worth about $41,000. Itau Unibanco Holding S.A. acquired a new position in Medical Properties Trust in the 1st quarter worth about $41,000. Farther Finance Advisors LLC raised its holdings in Medical Properties Trust by 49.5% in the 1st quarter. Farther Finance Advisors LLC now owns 7,875 shares of the real estate investment trust's stock worth $47,000 after purchasing an additional 2,606 shares during the period. Finally, Twin Tree Management LP acquired a new position in Medical Properties Trust in the 1st quarter worth about $48,000. Institutional investors and hedge funds own 71.79% of the company's stock.

Wall Street Analyst Weigh In

MPW has been the subject of several research reports. Royal Bank Of Canada cut their price objective on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a research note on Monday, June 30th. Wells Fargo & Company cut their price objective on Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating for the company in a research note on Wednesday, August 27th. Zacks Research upgraded Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research note on Wednesday, August 20th. Finally, Wall Street Zen lowered Medical Properties Trust from a "hold" rating to a "sell" rating in a research note on Saturday, July 5th. One investment analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $5.40.

View Our Latest Analysis on MPW

Medical Properties Trust Price Performance

Shares of MPW stock traded up $0.54 during trading hours on Friday, reaching $5.15. The company had a trading volume of 21,786,950 shares, compared to its average volume of 7,333,322. The company has a debt-to-equity ratio of 2.00, a quick ratio of 2.76 and a current ratio of 2.76. The stock has a fifty day moving average of $4.28 and a 200-day moving average of $4.85. The company has a market capitalization of $3.10 billion, a price-to-earnings ratio of -2.15 and a beta of 1.35. Medical Properties Trust, Inc. has a 12-month low of $3.51 and a 12-month high of $6.55.

Medical Properties Trust (NYSE:MPW - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The company had revenue of $240.36 million during the quarter, compared to analysts' expectations of $231.90 million. Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. Medical Properties Trust's revenue for the quarter was down 9.8% on a year-over-year basis. During the same quarter last year, the company earned $0.23 earnings per share. On average, equities analysts anticipate that Medical Properties Trust, Inc. will post 0.78 earnings per share for the current year.

Medical Properties Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 9th. Stockholders of record on Thursday, September 11th will be given a $0.08 dividend. The ex-dividend date is Thursday, September 11th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 6.2%. Medical Properties Trust's dividend payout ratio is -13.39%.

Medical Properties Trust Company Profile

(Free Report)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Featured Articles

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.